Investor Presentaiton
Priorities for Q3
1. Partner coordination and resource mobilization
•
•
State-level mapping and advocacy to help secure inclusion of zinc/ORS on state
essential medicines lists and increased awareness of OTC status.
Joint workplan/Activity mapping document
•
Joint M&E Framework
2. Provider and consumer demand generation
•
Launch marketing campaign in urban Lagos, Kano and Rivers
•
Baseline survey for zinc/ORS scale-up
3. Supplier engagement
•
•
Help suppliers drive down costs by identifying cost-saving opportunities
Formalize packaging formats and design
4. Regulatory environment
• Work with NAFDAC to clarify position on WHO-approved ORS formulation
•
• Continue to monitor registration approvals for zinc and ORS
| 17View entire presentation